Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma

Completed · Phase 2

Conditions studied: Low Grade Astrocytomas

In brief

RATIONALE: Current therapies for children with low grade astrocytomas that have not responded to standard therapy provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of children with low grade astrocytomas that have not responded to standard therapy PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on children (\> 6 months of age) with low grade astrocytomas that has not responded to standard therapy.

Key facts

Study ID

NCT00003468

Run by

Burzynski Research Institute

People needed

11

Starts

1996-07-01

Expected to finish

2004-07-01

Last updated by the study team

2023-11-21

Who can join

Age: 1 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Burzynski Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.